Robert Stagg, PharmD

Rare Disease / Clinical Research

Tempest Therapeutics

PI on 1 trial

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Combined hepatocellular carcinoma and cholangiocarcinoma
Squamous cell carcinoma of pancreas

Clinical trials (1)

NCT03829436

Verify independently

ClinicalTrials.gov PI search for Robert Stagg, PharmD

Other specialists for Combined hepatocellular carcinoma and cholangiocarcinoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

William R. Jarnagin, MD, MD
Memorial Sloan Kettering Cancer Center
NY
Manuel Häckl, MD
Basilea Pharmaceutica International Ltd, Allschwil
Nilofer S Azad, MD
JHU Sidney Kimmel Comprehensive Cancer Center LAO
MD
Richard Kim
SWOG Cancer Research Network
Dustin A Deming, M.D
ECOG-ACRIN Cancer Research Group
WI
David Hsieh
ECOG-ACRIN Cancer Research Group
Tim F Greten, M.D., M.D
National Cancer Institute (NCI)
MD
Lewis R. Roberts, MD, PhD
Mayo Clinic in Rochester

See all specialists for Combined hepatocellular carcinoma and cholangiocarcinoma →

← Back to specialists directory